Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why HEXO (TSX:HEXO) Could Be the Cannabis Industry’s Next Acquisition Target

Published 2018-12-05, 01:34 p/m
Updated 2018-12-05, 01:46 p/m
Why HEXO (TSX:HEXO) Could Be the Cannabis Industry’s Next Acquisition Target

Why HEXO (TSX:HEXO) Could Be the Cannabis Industry’s Next Acquisition Target

I recently wrote an article on why I believe Hexo Corp. (TSX:HEXO), formerly The Hydropothecary Corporation, was the “the only cannabis stock I would recommend investors consider.” Since my mid-year article, shares of the up and coming cannabis producer increased substantially, nearly doubling to all-time highs in October before coming down to earth (shares are now only 15% higher, which is still not a bad rate of return compared to most other producers since then).

This assessment was of course based on pure conjecture of where I saw Hexo heading relative to its peers, and what drivers might take it higher over the long term either as a standalone business or an acquisition opportunity.

Recent reports highlighting the possibility that Hexo may indeed be the next acquisition target on the block in the Canadian cannabis space have focused on many of the same items I pointed out in my previous piece. Namely, Hexo is in a unique position with respect to the amount of supply the company has secured with end buyers (at a relatively impressive price/margin), a cost per gram that rivals much larger companies, and a management team willing to do what it takes to make deals happen in cannabis sub-niches that don’t yet exist (i.e., cannabis infused beverages).

The second largest shareholder in Hexo, Riposte Capital, published a letter in September underscoring concerns with the company’s valuation, which apparently has gained significant interest among other cannabis companies in a sector that continues to undergo consolidation.

While it remains unclear exactly which firms may be interested in taking a shot at Hexo, the valuation gap between mid-range producers such as Hexo and its larger peers is hard to ignore, and it appears others in the industry are on the same page in this regard.

Bottom line

Given the lack of a track record of profitability (or real revenues in many cases, for that matter), long-term investors cannot reasonably take a position in any firm, and any sort of fundamentals that would support a long-term investment or outlook in any producer.

That said, for those speculative types, opportunities remain for those wishing to gamble to place bets on the companies that have demonstrated the ability to secure sales agreements, maintain impressive margins, and have the potential to grow outside of the commoditized cannabis flower into other sectors that should be more profitable in the long-run, such as Hexo.

The management team appears to be more experienced in creating value than most other producers at this point, and the valuation gap between Hexo and others remains unwarranted, especially if an acquisition is really on the table.

Stay Foolish, my friends.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.